Immunogenicity and Safety of Sabin-IPV Replacement Vaccination
Clinical trial NCT04051736 · COMPLETED
Trial details
- NCT number
- NCT04051736
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-12-28
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.